Dark Forest Capital Management LP Reata Pharmaceuticals Inc Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$24.12 - $39.6 $4,968 - $8,157
-206 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$25.61 - $110.96 $4,071 - $17,642
159 Added 338.3%
206 $5,000
Q3 2021

Nov 12, 2021
BUY
$100.0 - $143.02 $4,700 - $6,721
47 New
47 $5,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email